Engineered toxins "zymoxins" are activated by the HCV NS3 protease by removal of an inhibitory protein domain

Assaf Shapira, Meital Gal-Tanamy, Limor Nahary, Dana Litvak-Greenfeld, Romy Zemel, Ran Tur-Kaspa, Itai Benhar

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Engineered toxins "zymoxins" are activated by the HCV NS3 protease by removal of an inhibitory protein domain'. Together they form a unique fingerprint.

Medicine & Life Sciences